E. Volonaki

Vascular endothelial growth factor-mediated induction of angiogenesis by human rhinoviruses.

N. Papadopoulos, A. Bossios, S. Tsigkos, 2006, The Journal of allergy and clinical immunology.

Rhinovirus-induced basic fibroblast growth factor release mediates airway remodeling features

N. Papadopoulos, S. Johnston, D. Kletsas, 2012, Clinical and Translational Allergy.

Synergistic effects of fluticasone propionate and salmeterol on inhibiting rhinovirus‐induced epithelial production of remodelling‐associated growth factors

S. Psarras, P. Xepapadaki, D. Gourgiotis, 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Short article: Adalimumab as a second-line biological therapy in children with refractory ulcerative colitis

M. Elawad, N. Shah, M. Mutalib, 2015, European journal of gastroenterology & hepatology.

THE RE-PUBLICATION OF THE ATHENIAN LAWS IN THE LAST DECADE OF THE FIFTH CENTURY B.C

E. Volonaki, 2005 .

Evidence supporting safe diagnosis of coeliac disease in children with antitissue transglutaminase titre ≥5 times upper limit of normal

P. Ramani, S. Paul, B. Sandhu, 2022, Archives of Disease in Childhood.

Cytomegalovirus infection in a child with menetrier’s disease: a case report

E. Roma, F. Haliotis, S. Avlonitis, 2007 .

Unusual Presentation of Gastric Polyp in a Young Child: A Case Report

M. Shoukry, E. Volonaki, T. Yousif, 2017 .

A rare case of neonatal systemic xanthogranulomatosis with severe hepatic disease and metachronous skin involvement.

M. Anagnostakou, K. Stefanaki, K. Katsibardi, 2012, Journal of pediatric hematology/oncology.

Gastrointestinal Endoscopy and Mucosal Biopsy in the First Year of Life: Indications and Outcome

N. Sebire, M. Elawad, O. Borrelli, 2012, Journal of pediatric gastroenterology and nutrition.

Histological findings in infants with Gastrointestinal food allergy are associated with specific gastrointestinal symptoms; retrospective review from a tertiary centre

N. Sebire, M. Elawad, O. Borrelli, 2015, BMC Clinical Pathology.

Short article: Adalimumab as a second-line biological therapy in children with refractory ulcerative colitis

M. Elawad, N. Shah, M. Mutalib, 2015, European journal of gastroenterology & hepatology.